Endocrine Disruptor Screening Program (EDSP); Near-Term Strategies for Implementation; Notice of Availability and Request for Comment; Extension of Comment Period, 86644 [2023-27405]

Download as PDF 86644 Federal Register / Vol. 88, No. 239 / Thursday, December 14, 2023 / Notices field to access the document. At this time, the Commission has suspended access to the Commission’s Public Reference Room, due to the proclamation declaring a National Emergency concerning the Novel Coronavirus Disease (COVID–19), issued by the President on March 13, 2020. For assistance, contact the Federal Energy Regulatory Commission at FERCOnlineSupport@ferc.gov or call toll-free, (886) 208–3676 or TYY, (202) 502–8659. The Commission’s Office of Public Participation (OPP) supports meaningful public engagement and participation in Commission proceedings. OPP can help members of the public, including landowners, environmental justice communities, Tribal members and others, access publicly available information and navigate Commission processes. For public inquiries and assistance with making filings such as interventions, comments, or requests for rehearing, the public is encouraged to contact OPP at (202) 502–6595 or OPP@ ferc.gov. Dated: December 7, 2023. Kimberly D. Bose, Secretary. [FR Doc. 2023–27390 Filed 12–13–23; 8:45 am] BILLING CODE 6717–01–P ENVIRONMENTAL PROTECTION AGENCY [EPA–HQ–OPP–2023–0474; FRL–11384–02– OCSPP] Endocrine Disruptor Screening Program (EDSP); Near-Term Strategies for Implementation; Notice of Availability and Request for Comment; Extension of Comment Period Environmental Protection Agency (EPA). ACTION: Notice; extension of comment period. AGENCY: lotter on DSK11XQN23PROD with NOTICES1 VerDate Sep<11>2014 17:39 Dec 13, 2023 Jkt 262001 (Authority: 7 U.S.C. 136 et seq. and 21 U.S.C. 346a) Dated: December 6, 2023. Michal Freedhoff, Assistant Administrator, Office of Chemical Safety and Pollution Prevention. In the Federal Register of October 27, 2023, EPA announced the availability of and solicited comment on near-term strategies to help the Agency meet its obligations and commitments under the Federal Food, Drug, and Cosmetic Act (FFDCA), which requires, that EPA screen for and protect against endocrine disrupting effects in humans. This document extends the comment period, which was scheduled to end on December 26, 2023, for 60 days. DATES: The comment period for the document published in the Federal Register of October 27, 2023, at 88 FR 73841 (FRL–11384–01–OCSPP) is SUMMARY: extended. Comments must be received on or before February 26, 2023. ADDRESSES: Submit your comments, identified by docket identification (ID) number EPA–HQ–OPP–2023–0474, through the Federal eRulemaking Portal at https://www.regulations.gov. Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. Additional instructions on commenting and visiting the docket, along with more information about dockets generally, is available at https://www.epa.gov/dockets. FOR FURTHER INFORMATION CONTACT: Catherine Aubee, Endocrine Disruptor Screening Program (7505T), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460–0001; main telephone number: (202) 566– 1030; email address: pesticidequestions@epa.gov. SUPPLEMENTARY INFORMATION: To give stakeholders additional time to review materials and prepare comments, EPA is hereby extending the comment period established in the Federal Register document of October 27, 2023, at 88 FR 73841 (FRL–11884– 01–OCSPP) for 60 days, from December 26, 2023, to February 26, 2023. More information on the action can be found in the Federal Register of October 27, 2023. To submit comments or access the docket, please follow the detailed instructions provided under ADDRESSES. If you have questions, consult the technical person listed under FOR FURTHER INFORMATION CONTACT. [FR Doc. 2023–27405 Filed 12–13–23; 8:45 am] BILLING CODE 6560–50–P FEDERAL COMMUNICATIONS COMMISSION [GN Docket No. 18–122; DA 23–1132; FR ID 190109] Wireless Telecommunications Bureau Adopts Final Deadlines for Submission of C-Band Reimbursement Claims Federal Communications Commission. ACTION: Notice. AGENCY: PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 In this document, the Wireless Telecommunications Bureau (WTB or Bureau) adopts two final reimbursement claims submission deadlines by which eligible incumbents and other eligible stakeholders are required to submit any outstanding transition-related claims to the C-band Relocation Payment Clearinghouse (RPC) for processing as part of the ongoing transition of the 3.7–4.2 GHz band (C-band). On October 13, 2023, the Bureau issued a Public Notice seeking comment on certain proposals advanced by the RPC, AT&T, Verizon, and SES relating to the conclusion of the C-band transition reimbursement program and wind down of the RPC’s operations. After review of the record, WTB adopts: February 5, 2024, as the submission deadline to the RPC for all reimbursement claims for costs incurred and paid by claimants as of December 31, 2023, including all lump sum election claims by incumbent earth station operators; and July 1, 2024, as the submission deadline to the RPC for all reimbursement claims for costs incurred and paid by claimants after December 31, 2023. DATES: Applicable December 5, 2023. ADDRESSES: Federal Communications Commission, 45 L St NE, Washington, DC 20554. People with Disabilities. To request materials in accessible formats (braille, large print, electronic files, audio format) for people with disabilities, send an email to fcc504@fcc.gov or call the Consumer & Governmental Affairs Bureau at (202) 418–0530. FOR FURTHER INFORMATION CONTACT: For additional information on this proceeding, contact Susan Mort of the Wireless Telecommunications Bureau, at (202) 418–2429 or Susan.Mort@ fcc.gov. SUPPLEMENTARY INFORMATION: This is a summary of the Public Notice, Wireless Telecommunications Bureau Adopts Final Deadlines for Submission of CBand Reimbursement Claims, released on December 5, 2023. The full text of this document is available for public inspection online at https:// www.fcc.gov/document/wtb-adopts-cband-claim-deadlines. 1. With this Public Notice, the Wireless Telecommunications Bureau (WTB or Bureau) adopts two final reimbursement claims submission deadlines by which eligible incumbents and other eligible stakeholders are required to submit any outstanding transition-related claims to the C-band Relocation Payment Clearinghouse (RPC) for processing as part of the ongoing transition of the 3.7–4.2 GHz SUMMARY: E:\FR\FM\14DEN1.SGM 14DEN1

Agencies

[Federal Register Volume 88, Number 239 (Thursday, December 14, 2023)]
[Notices]
[Page 86644]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-27405]


=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2023-0474; FRL-11384-02-OCSPP]


Endocrine Disruptor Screening Program (EDSP); Near-Term 
Strategies for Implementation; Notice of Availability and Request for 
Comment; Extension of Comment Period

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: In the Federal Register of October 27, 2023, EPA announced the 
availability of and solicited comment on near-term strategies to help 
the Agency meet its obligations and commitments under the Federal Food, 
Drug, and Cosmetic Act (FFDCA), which requires, that EPA screen for and 
protect against endocrine disrupting effects in humans. This document 
extends the comment period, which was scheduled to end on December 26, 
2023, for 60 days.

DATES: The comment period for the document published in the Federal 
Register of October 27, 2023, at 88 FR 73841 (FRL-11384-01-OCSPP) is 
extended. Comments must be received on or before February 26, 2023.

ADDRESSES: Submit your comments, identified by docket identification 
(ID) number EPA-HQ-OPP-2023-0474, through the Federal eRulemaking 
Portal at https://www.regulations.gov. Follow the online instructions 
for submitting comments. Do not submit electronically any information 
you consider to be Confidential Business Information (CBI) or other 
information whose disclosure is restricted by statute. Additional 
instructions on commenting and visiting the docket, along with more 
information about dockets generally, is available at https://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Catherine Aubee, Endocrine Disruptor 
Screening Program (7505T), Office of Pesticide Programs, Environmental 
Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-
0001; main telephone number: (202) 566-1030; email address: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    To give stakeholders additional time to review materials and 
prepare comments, EPA is hereby extending the comment period 
established in the Federal Register document of October 27, 2023, at 88 
FR 73841 (FRL-11884-01-OCSPP) for 60 days, from December 26, 2023, to 
February 26, 2023. More information on the action can be found in the 
Federal Register of October 27, 2023.
    To submit comments or access the docket, please follow the detailed 
instructions provided under ADDRESSES. If you have questions, consult 
the technical person listed under FOR FURTHER INFORMATION CONTACT.

(Authority: 7 U.S.C. 136 et seq. and 21 U.S.C. 346a)

    Dated: December 6, 2023.
Michal Freedhoff,
Assistant Administrator, Office of Chemical Safety and Pollution 
Prevention.
[FR Doc. 2023-27405 Filed 12-13-23; 8:45 am]
BILLING CODE 6560-50-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.